Nutshell Therapeutics Receives FDA Clearance for Phase 1 Trial of NTS071

Nutshell Therapeutics announced that the US FDA has cleared its Investigational New Drug (IND) application for NTS071, an oral, small molecule alloste...
Home/KnloSights/Clinical Trial Updates/Nutshell Therapeutics Receives FDA Clearance for Phase 1 Trial of NTS071